In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

444 News Items found
Q&A
Molecular model of olaparib
The Latest on Genetic Testing for BRCA Mutations in Breast Cancer

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.
In the Clinic
MSK patient receiving chemotherapy
6 Breakthroughs That Are Changing Chemotherapy for People with Breast Cancer

Discover some of the latest innovations in chemotherapy for breast cancer.
Breast cancer patient Mikaela Rix
Mikaela’s Story: Facing Breast Cancer as a Woman in Her 20s

Former college lacrosse player Mikaela Rix, diagnosed at age 26, accessed a wide range of resources offered by MSK’s new program tailored for young women with breast cancer.
Dr. Colleen McCarthy
Patient Information Sessions Focus on Breast Cancer in October

In honor of Breast Cancer Awareness Month in October, Memorial Sloan Kettering (MSK) held two Information Sessions for breast cancer patients, caregivers, and those at increased risk for the disease.
Finding
MSK Physician-in-Chief José Baselga presents at the ASCO meeting
Targeted Therapy Slows Growth of Most Common Type of Advanced Breast Cancer

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.
Feature
A woman considering birth control pills
Birth Control and Cancer Risk: 6 Things You Should Know

Find out what an MSK gynecologist thinks you should know about birth control and cancer risk.
In the Clinic
Illustration of breast cancer cell
Targeted Drug Shows Promise Against HER2-Positive Breast Cancer That Stops Responding to Other Drugs

MSK medical oncologist Shanu Modi is the lead author of a new paper detailing the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. Results from this study were also presented at the San Antonio Breast Cancer Symposium.
Rachel Samuels Rand (l) with her husband, Brendan Rand.
3-D Nipple Tattoos After Breast Cancer Surgery: An MSK Specialty

Learn how specialists at Memorial Sloan Kettering tattoo highly realistic nipples and areolas on people who have had them removed during surgery for breast cancer.
Memorial Sloan Kettering Ralph Lauren Center nurse Jasmine Gibson, breast cancer patient Maria Tucker, and nurse Margaret Bediones
Expert Breast Cancer Treatment in Harlem at MSK’s Ralph Lauren Center

See how experts at Memorial Sloan Kettering Cancer Center's Ralph Lauren Center cared for Maria close to home.
Finding
Radiologist Maxine Jochelson
Imaging and Artificial Intelligence Tools Help Predict Response to Breast Cancer Therapy

For HER2-positive breast cancers, MRI scans that employ machine-learning algorithms can provide more guidance than biopsies alone.